Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

By El-Galley R.E.S.   Petros J.A.   Sanders W.H.   Keane T.E.   Galloway N.T.M.   Cooner W.H.   Graham S.D.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 200-204

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer

By Stephan C.   Jung K.   Diamandis E.P.   Rittenhouse H.G.   Lein M.   Loening S.A.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 2-8

Elsevier

Access to resources Recommend Favorite

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era

By McCormack R.T.   Rittenhouse H.G.   Finlay J.A.   Sokoloff R.L.   Wang T.J.   Wolfert R.L.   Lilja H.   Oesterling J.E.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 729-744

Elsevier

Access to resources Recommend Favorite

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

By Ghossein R.A.   Rosai J.   Scher H.I.   Seiden M.   Zhang Z.-F.   Sun M.   Chang G.   Berlane K.   Krithivas K.   Kantoff P.W.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

By Gilliland F.D.   Hunt W.C.   Key C.R.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite